Drug Updates

Drug updates provide the latest information and relevant warnings and notifications.

Update on Drugs & Devices: January-February 2022

Drug update covering: Adalimumab-adbm for SC use - Cyltezo®, Tralokinumab for SC use - Adtralza® (in Canada), Tralokinumab-ldrm for SC use - Adbry™ (in US), Melanoma vaccine for IV use - BNT111, Adalimumab-aqvh for SC use - Yusimry™, and more...

Update on Drugs and Drug News: October, 1997

Update on: Amphotericin B Lipid Complex Injection Abelcet®Butenafine HCl Cream 1% Mentax® Itraconazole Sporanox® Acitretin Soriatane® Penciclovir cream 1% Denavir® Valacyclovir Valtrex® Laser device Sharplan Silktouch laser® Permethrin lotion Nix® Ivermectin Mectizan® (6 mg tablet)

Update on Drugs and Drug News: March 2011

Update on drugs, approval dates, and comments. Spinosad 0.9% cream rinse (Natroba™), Light emitting diode (LED) skin rejuvenation system (Tanda™ Professional Rejuvenate), Voclosporin Voclera™ (ISA247) are covered.

Update on Drugs and Drug News – October 2007

Update on Nanocrystalline Silver Cream NPI32101, Daptomycin for Injection CUBICIN®, Oral Alitretinoin BAL4079, Smallpox Vaccine ACAM2000, and news about new US FDA regulations.

Update on Drugs & Devices: November-December 2021

The update covers Difelikefalin for IV use - Korsuva™ (Vifor Pharma, Cara Therapeutics), Topical MEK inhibitor - NFX-179 (NFlextion Therapeutics), Maralixibat oral solution - Livmarli™ (Mirum Pharmaceuticals), Ruxolitinib cream 1.5% - Opzelura™ (Incyte), Ruxolitinib tablets - Jakafi® (Incyte), and Avacopan capsules - Tavneos™ (ChemoCentryx).

Update on Drugs and Drug News – December 2006 – January 2007

Update on Polymethylmethacrylate/ Bovine Collagen ArteFill® Artes Medical, Polyphenon® E Ointment 15% MediGene AG/ Bradley Pharmaceuticals, and drug news on melanoma and new vaccines.

Update on Drugs and Drug News: January 2000

Update on: Pyrethrins/Piperonyl butoxide Rid aerosol foam mousse Fluocinolone acetonide 0.01% Derma-Smoothe/FS Quinupristin/ Dalfopristin Synercid IV Rid Lice Egg Loosener Gel Tacrolimus Protopic Ointment Docosanol

Update on Drugs and Drug News – February 2006

Update on Doxycycline Oracea® CollaGenex, Hydrogel Dressing MimyX™ Cream Stiefel Laboratories, and Aluma™ Skin Renewal System with FACES™ Lumenis.

Update on Drugs and Drug News: May 2001

Update on: Moxifloxacin HCl Avelox Recombinant Human Iduronidase (IDUA) Neurotoxins Botox Graftskin Apligraf

Update on Drugs and Drug News: February 2009

Update on Alitretinoin (Toctino®), Denileukin Diftitox (Ontak™), Bimatoprost Ophthalmic 0.03% Solution (LATISSE®), Maraviroc (SELZENTRY®), Clindamycin Phosphate 1.2% + Benzoyl Peroxide 2.5% (Acanya® Gel), Etanercept (Enbrel®).

Update on Drugs and Drug News: April 2012

Update on drugs, approval dates, and comments. Ivermectin 0.5% lotion (Sklice™), Ipilimumab (Yervoy™), Vemurafenib (Zelboraf®), are covered, as well as the Cellulite removal laser device Cellulaze™ Cellulite Laser Workstation.

Update on Drugs and Drug News – March 2007

Update on Diclofenac Sodium 3% Gel Solaraze®, Retapamulin Ointment 1% Altabax™, Calcium Hydroxylapatite Microspheres in Water-based Gel Radiesse®, Rose Bengal Disodium 10% PV-10, and Taxane Potentiator STA-4783.

Update on Drugs and Drug News: December 2001

Update on: Tazarotene 0.1% Tazorac® Botulinum Toxin BOTOX® Tacrolimus Ointment Protopic® Amlexanox 5% paste Aptheal® Tenofovir Disoproxil Fumarate Viread™ HIV Drug Resistance Test Trugene™ HIV-1 Genotyping Test

Update on Drugs and Drug News: June 2009

Update on Golimumab (Simponi™) Centocor/Schering-Plough, Darunavir (PREZISTA™) Tibotec/Janssen-Ortho, Telavancin (Arbelic™) Theravance/Astellas, and news from US FDA.

Update on Drugs and Drug News – December 2007 – January 2008

Update on Loratadine Dry Syrup 1% Claritin® Schering-Plough, Valacyclovir Hydrochloride TEVA Pharmaceutical Industries, and news about Anti-dandruff, anti-acne and anti-melanoma agents.

Update on Drugs & Devices: March-April 2022

This update covers Adalimumab biosimilar - Yuflyma™ (Celltrion Healthcare), Adalimumab biosimilar - Simlandi™ (Alvotech/JAMP Pharma), Abrocitinib tablet - Cibinqo® (Pfizer), Upadacitinib tablet - Rinvoq® (AbbVie), Risankizumab-rzaa SC injection - Skyrizi® (AbbVie), and HA-based dermal filler - Juvéderm® Volbella® XC (AbbVie/ Allergan Aesthetics).

Update on Drugs and Drug News: January 2010

Update on Capsaicin 8% Patch Qutenza™, Alitretinoin Capsule Toctino® as well as news about a recent study by Kenter et al.* explored the efficacy of a human papillomavirus (HPV) vaccine.

Update on Drugs & Devices: July-August 2022

Update covering: Benzoyl peroxide 5% cream, Isotretinoin ointment, Tapinarof 1% cream, Baricitinib tablets, and Dupilumab for SC injection.

Update on Drugs & Devices: September – October 2022

Update covering: Roflumilast cream 0.3% (Zoryve™), Ruxolitinib cream 1.5% (Opzelura™), HA-based dermal filler (Juvéderm® Volux™ XC), Abrocitinib tablets (Cinbinqo®), LetibotulinumtoxinA for injection (Letybo®), Berotralstat capsules (Orladeyo®), Mogamulizumab IV infusion (Poteligeo®), and Avacopan capsules (Tavneos®).

Update on Drugs & Devices: January – February 2023

Update covering: Deucravacitinib tablets (Sotyktu™), mRNA vaccine + pembrolizumab IV combination therapy (mRNA-4157/V940 + Keytruda®), Adalimumab-aacf SC injection (Idacio®), Dupilumab for SC injection (Dupixent®), and Spesolimab IV injection (Spevigo®).

Update on Drugs & Devices: March – April 2023

Update on Abrocitinib tablet (Cibinqo®), Lanadelumab-flyo SC injection (Takhzyro®), Berdazimer gel, 10.3% (SB206), Methotrexate oral solution, 2 mg/mL (Jylamvo®), and Anticancer plasmid DNA vaccine (ITI-3000).

Update on Drugs & Devices: May – June 2023

Update on Targeted alkali thermolysis (TAT) technology (Brella™ 3-miniute SweatControl Patch™), Retifanlimab-dlwr for IV infusion (Zynyz™), Spesolimab IV for IV infusion (Spevigo®) and CRISPR-based therapy (NTLA-2002).

Update on Drugs & Devices: July – August 2023

Update on Roflumilast cream 0.3% (Zoryve™), Adalimumab-aaty SC use (Yuflyma®), Beremagene geperpavec-svdt topical gene therapy (Vyjuvek™), Molecular imaging device (Orlucent®), Tirbanibulin ointment 1% w/w (Onakta™), Pegunigalsidase alfaiwxj for IV use (Elfabrio®), Autologous cell harvesting device (Recell® System), and Odevixibat capsules/pellets (Bylvay®).

Update on Drugs & Devices: November-December 2023

Update on Bimekizumab-bkzx for SC injection (Bimzelx®), Clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%fixed-dose topical gel (Cabtreo™), Roflumilast cream 0.3% (Zoryve®), Nivolumab for IV use (Opdivo®), Secukinumab for IV use (Cosentyx®)

Update on Drugs & Devices: September-October 2023

Update on Cantharidin topical solution 0.7% (Ycanth™), Ritlecitinib capsules (Litfulo™), Clascoterone cream 1% (Winlevi®), and Isotretinoin capsules micronized formulation (Absorica LD®).

Update on Drugs & Devices: January – February 2024

Update on Roflumilast foam, 0.3% (Zoryve®), Birch triterpenes gel (Filsuvez®), Rapamycin anhydrous gel, 3.9% (Qtorin™), Bimekizumab-bkzx for SC use (Bimzelx®), Secukinumab for SC use (Cosentyx®), and Ustekinumab-auub for SC/IV use (Wezlana™).

Update on Drugs & Devices: March – April 2024

Update on Adalimumab-ryvk for SC injection (Simlandi®), B-Raf inhibitor gel (LUT014), Lifileucel tumorinfiltrating lymphocyte (TIL) suspension for IV use (Amtagvi™), Berdazimer topical gel, 10.3% (Zelsuvmi™), Artificial intelligencepowered skin cancer diagnostic tool (DermaSensor™), Smallpox vaccine (ACAM2000®), Oral brincidofovir (Tembexa®), Ritlecitinib tosylate capsules (Litfulo™), Ustekinumab biosimilar (Jamteki™).

Update on Drugs & Devices: November – December 2022

Update covering: Deucravacitinib tablets (Sotyktu™), DaxibotulinumtoxinA-lanm IM injection (Daxxify™), Dupilumab for SC injection (Dupixent®), Spesolimab-sbzo IV injection (Spevigo®) and Selumetinib capsules (Koselugo™).

POPULAR

Advertisement